合成路线1
该中间体在本合成路线中的序号:
(I) Synthesis of curcumin was first described by Lampe et al. In our laboratory curcumin has been synthesized by condensing vanillin (I) and acetyl acetone (II) in a medium of ethyl acetate using tributylborate as boron complex to avoid Knoevenagel condensation at C-3 of acetyl acetone. Curcumin is isolated from the reaction mixture by acidification and extraction with ethyl acetate. The organic layers are washed until neutral, dried and the solvent is removed. purified by chromatography over silica gel using ether/petroleum ether as the solvent.
【1】
Scrimal, R.C.; Curcumin. Drugs Fut 1987, 12, 4, 331.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
22701 |
4-hydroxy-3-methoxybenzaldehyde
|
121-33-5 |
C8H8O3 |
详情 | 详情
|
(II) |
16620 |
3-[(3R,4R)-3,4-dimethylhexahydro-4-pyridinyl]phenol
|
119193-19-0 |
C13H19NO |
详情 | 详情
|
合成路线2
该中间体在本合成路线中的序号:
(VI) The protection of 4-bromo-2-methoxyphenol (I) with ethyl vinyl ether (II) and TsOH in dichloromethane gives the ethoxyethyl ether (III), which is treated with n-BuLi in THF to yield the phenyl lithium compound (IV). The reaction of (IV) with 2H-labeled DMF (V), followed by hydrolysis with HCl, affords the labeled 4-hydroxy-3-methoxybenzaldehyde (VI), which is finally condensed with pentane-2,4-dione (VII) by means of B2O3 and tetrahydroquinoline in DMF.
【1】
Threadgill, M.D.; Parveen, I.; Labelled compounds of interest as antitumour agents - VII. [H-2]- and [C-14]-curcumin. J Label Compd Radiopharm 2000, 43, 9, 883.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
45436 |
4-bromo-2-methoxyphenol
|
7368-78-7 |
C7H7BrO2 |
详情 | 详情
|
(II) |
18762 |
1-Ethoxyethylene; Ethyl vinyl ether;Ethoxyethene |
109-92-2 |
C4H8O |
详情 | 详情
|
(III) |
45437 |
5-bromo-2-(1-ethoxyethoxy)phenyl methyl ether; 4-bromo-1-(1-ethoxyethoxy)-2-methoxybenzene
|
|
C11H15BrO3 |
详情 |
详情
|
(IV) |
45438 |
[4-(1-ethoxyethoxy)-3-methoxyphenyl]lithium
|
|
C11H15LiO3 |
详情 |
详情
|
(V) |
33491 |
Dimethylformamide
|
68-12-2 |
C3H7NO |
详情 | 详情
|
(V) |
45439 |
dimethylformamide
|
|
C3H7NO |
详情 |
详情
|
(VI) |
22701 |
4-hydroxy-3-methoxybenzaldehyde
|
121-33-5 |
C8H8O3 |
详情 | 详情
|
(VI) |
45440 |
4-hydroxy-3-methoxybenzaldehyde
|
21-59-0 |
C8H8O3 |
详情 | 详情
|
(VII) |
11620 |
2,4-Pentanedione;acetylacetone |
123-54-6 |
C5H8O2 |
详情 | 详情
|
合成路线3
该中间体在本合成路线中的序号:
(VI) The protection of 4-bromo-2-methoxyphenol (I) with ethyl vinyl ether (II) and TsOH in dichloromethane gives the ethoxyethyl ether (III), which is treated with n-BuLi in THF to yield the phenyl lithium compound (IV). The reaction of (IV) with 14C-labeled DMF (V), followed by hydrolysis with HCl, affords the labeled 4-hydroxy-3-methoxybenzaldehyde (VI), which is finally condensed with pentane-2,4-dione (VII) by means of B2O3 and tetrahydroquinoline in DMF.
【1】
Threadgill, M.D.; Parveen, I.; Labelled compounds of interest as antitumour agents - VII. [H-2]- and [C-14]-curcumin. J Label Compd Radiopharm 2000, 43, 9, 883.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
45436 |
4-bromo-2-methoxyphenol
|
7368-78-7 |
C7H7BrO2 |
详情 | 详情
|
(II) |
18762 |
1-Ethoxyethylene; Ethyl vinyl ether;Ethoxyethene |
109-92-2 |
C4H8O |
详情 | 详情
|
(III) |
45437 |
5-bromo-2-(1-ethoxyethoxy)phenyl methyl ether; 4-bromo-1-(1-ethoxyethoxy)-2-methoxybenzene
|
|
C11H15BrO3 |
详情 |
详情
|
(IV) |
45438 |
[4-(1-ethoxyethoxy)-3-methoxyphenyl]lithium
|
|
C11H15LiO3 |
详情 |
详情
|
(V) |
33491 |
Dimethylformamide
|
68-12-2 |
C3H7NO |
详情 | 详情
|
(V) |
45441 |
dimethylformamide
|
|
C3H7NO |
详情 |
详情
|
(VI) |
22701 |
4-hydroxy-3-methoxybenzaldehyde
|
121-33-5 |
C8H8O3 |
详情 | 详情
|
(VI) |
45442 |
4-hydroxy-3-methoxybenzaldehyde
|
|
C8H8O3 |
详情 |
详情
|
(VII) |
11620 |
2,4-Pentanedione;acetylacetone |
123-54-6 |
C5H8O2 |
详情 | 详情
|
合成路线4
该中间体在本合成路线中的序号:
(I) TMK 688 is derived trom the condensation ot 5-(3'-methoxy-4'-hydroxyphenyl)-2,4-pentadienoic acid (IV) and N-aminoethyl 4-diphenylmethoxypiperidine (X) in the presence of ethyl chloroformate in dichloromethane.
Synthesis of intermediate (IV):
Vanillin (I) is protected with ethyl chloroformate to give (II), which is then treated with triethyl 4-phosphonocrotonate and followed by alkali hydrolysis to produce (IV).
【1】
Tasaka, K.; TMK-688. Drugs Fut 1988, 13, 12, 1056.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(A) |
22705 |
ethyl (E)-4-(diethoxyphosphoryl)-2-butenoate
|
|
C10H19O5P |
详情 |
详情
|
(B) |
22706 |
5-[4-(Ethoxycarbonyl)-3-methoxyphenyl]-2(E),4(E)-pentadienoic acid ethoxycarbonyl anhydride
|
|
C18H20O7 |
详情 |
详情
|
(I) |
22701 |
4-hydroxy-3-methoxybenzaldehyde
|
121-33-5 |
C8H8O3 |
详情 | 详情
|
(II) |
22702 |
ethyl 4-formyl-2-methoxyphenyl carbonate
|
|
C11H12O5 |
详情 |
详情
|
(III) |
22703 |
ethyl (2E,4E)-5-[4-[(ethoxycarbonyl)oxy]-3-methoxyphenyl]-2,4-pentadienoate
|
|
C17H20O6 |
详情 |
详情
|
(IV) |
22704 |
(2E,4E)-5-(4-hydroxy-3-methoxyphenyl)-2,4-pentadienoic acid
|
|
C12H12O4 |
详情 |
详情
|
(X) |
22707 |
2-[4-(benzhydryloxy)-1-piperidinyl]ethylamine; 2-[4-(benzhydryloxy)-1-piperidinyl]-1-ethanamine
|
|
C20H26N2O |
详情 |
详情
|
合成路线5
该中间体在本合成路线中的序号:
(I) The condensation of 4-hydroxy-3-methoxybenzaldehyde (I) with ethyl cyanoacetate (II) by means of NaOH in ethanol gives the 2-cyanopropenoate (III), which is then alkylated at the OH group with ethyl 2-bromoacetate (IV) by means of K2CO3 and tetrabutylammonium bromide in THF.
【1】
Tiwari, S.; et al.; Synthesis and antileishmanial activity of alpha-cyano ethyl propenoates - A new class of antileishmanials. Arzneim-Forsch Drug Res 1999, 49, 2, 144.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
22701 |
4-hydroxy-3-methoxybenzaldehyde
|
121-33-5 |
C8H8O3 |
详情 | 详情
|
(II) |
11877 |
Cyanoacetic acid ethyl ester; Ethyl 2-cyanoacetate; Ethyl cyanoacetate; Ethyl isocyanacetate
|
105-56-6 |
C5H7NO2 |
详情 | 详情
|
(III) |
30896 |
ethyl (Z)-2-cyano-3-(4-hydroxy-3-methoxyphenyl)-2-propenoate
|
|
C13H13NO4 |
详情 |
详情
|
(IV) |
16640 |
Ethyl 2-bromoacetate; Ethyl bromoacetate
|
105-36-2 |
C4H7BrO2 |
详情 | 详情
|
合成路线6
该中间体在本合成路线中的序号:
(I) Protection of vanillin (I) as the benzyl ether (II), followed by reaction with benzylmagnesium bromide, furnished alcohol (III). Oxidation of alcohol (III) to the corresponding ketone (IV) was achieved by means of chromium trioxide or, in an improved procedure, by Oppenauer oxidation with cyclohexanone and sodium tert-butoxide. Benzyl group cleavage in (IV) either with HBr, or by transfer hydrogenolysis, yielded phenol (V). Regioselective nitration of (V) gave the ortho-nitrophenol (VI). The title compound was finally obtained by methyl ether cleavage in (VI) with boiling HBr or with AlCl3 in pyridine.
【1】
Benes, J.; Vieira-Coelho, M.A.; Borges, N.; Freitas, A.P.; Soares-da-Silva, P.; Alves, P.C.; Learmonth, D.A.; Synthesis of 1-(3,4-dihydroxy-5-nitrophenyl)-2-phenyl-ethanone and derivatives as potent and long-acting peripheral inhibitors of catechol-O-methyltransferase. J Med Chem 2002, 45, 3, 685. |
【3】
Benes, J.; Soares da Silva, P.M.V.A.; Learmonth, D.A. (Portela & Ca., SA); Substd. 2-phenyl-1-(3,4-dihydroxy-5-nitrophenyl)-1-ethanones, their use in the treatment of some central and peripheral nervous system disorders and pharmaceutical compsns. containing them. EP 1010688; GB 2344819; WO 0037423 . |
【2】
Learmonth, D.; et al.; Synthesis of 1-(3,4-dihydroxy-5-nitrophenyl)-2-phenyl-ethanone and derivatives as potent and selective inhibitors of catechol-O-methyltransferase (COMT). 16th Int Symp Med Chem (Sept 18 2000, Bologna) 2000, Abst PA-34.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
22701 |
4-hydroxy-3-methoxybenzaldehyde
|
121-33-5 |
C8H8O3 |
详情 | 详情
|
(II) |
14045 |
4-(Benzyloxy)-3-methoxybenzaldehyde; 4-Benzyloxy-3-methoxybenzaldehyde
|
2426-87-1 |
C15H14O3 |
详情 | 详情
|
(III) |
59403 |
1-[4-(benzyloxy)-3-methoxyphenyl]-2-phenyl-1-ethanol
|
|
C22H22O3 |
详情 |
详情
|
(IV) |
59404 |
1-[4-(benzyloxy)-3-methoxyphenyl]-2-phenyl-1-ethanone
|
|
C22H20O3 |
详情 |
详情
|
(V) |
59405 |
1-(4-hydroxy-3-methoxyphenyl)-2-phenyl-1-ethanone
|
|
C15H14O3 |
详情 |
详情
|
(VI) |
59406 |
1-(4-hydroxy-3-methoxy-5-nitrophenyl)-2-phenyl-1-ethanone
|
|
C15H13NO5 |
详情 |
详情
|
合成路线7
该中间体在本合成路线中的序号:
(I) The condensation of vanillin (I) with epichlorohydrin (II) in ethanolic NaOH produced the glycidyl ether (III). Epoxide ring opening in (III) by means of tert-butylamine (IV) in EtOH furnished amino alcohol (V). The title dihydropyridine derivative was then obtained by reaction between aldehyde (V), methyl acetoacetate (VI), ammonia under Hantzsch condensation conditions, and was isolated after conversion to the hydrochloride salt.
【1】
Liang, J.-C.; Chen, I.-J.; Tsai, C.-H.; Liou, S.-F.; Wang, C.-S.; Yeh, J.-L.; The new generation dihydropyridine type calcium blockers, bearing 4-phenyl oxypropanolamine, display alpha-/beta-adrenoceptor antagonist and long-acting antihypertensive activities. Bioorg Med Chem 2002, 10, 3, 719. |
【2】
Donovan, S. (Allergan, Inc.); Method for treating a neoplasm. WO 0209743 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
22701 |
4-hydroxy-3-methoxybenzaldehyde
|
121-33-5 |
C8H8O3 |
详情 | 详情
|
(II) |
10146 |
Epichlorohydrin; 2-(Chloromethyl)oxirane
|
106-89-8 |
C3H5ClO |
详情 | 详情
|
(III) |
59599 |
3-methoxy-4-(2-oxiranylmethoxy)benzaldehyde
|
|
C11H12O4 |
详情 |
详情
|
(IV) |
17895 |
2-Amino-2-methylpropane; tert-butylamine; 2-methyl-2-propanamine
|
75-64-9 |
C4H11N |
详情 | 详情
|
(V) |
59600 |
4-[3-(tert-butylamino)-2-hydroxypropoxy]-3-methoxybenzaldehyde
|
|
C15H23NO4 |
详情 |
详情
|
(VI) |
11791 |
methyl 3-oxobutanoate; Methyl acetoacetate
|
105-45-3 |
C5H8O3 |
详情 | 详情
|
合成路线8
该中间体在本合成路线中的序号:
(I) Vanillin (I) was protected as the tetrahydropyranyl ether (II) by treatment with dihydropyran in the presence of pyridinium p-toluenesulfonate. Similarly, hydroxyacetone (III) was converted to the corresponding tetrahydropyranyl ether (IV). Aldol condensation between aldehyde (II) and ketone (IV) using LDA in cold THF furnished the hydroxy ketone (V). Removal of the tetrahydropyranyl protecting groups of (V) under acidic conditions caused the dehydration of the beta-hydroxyl group, affording the unsaturated ketone (VI). The phenolic hydroxyl group of (VI) was then protected as the trimethylsilyl ether (VII). After protection of the phenolic hydroxyl group of ferulic acid (VIII) as the silyl ether (IX), coupling between (IX) and (VII) by means of DCC and DMAP provided the silyl-protected ester (X). This was finally desilylated by treatment with HOAc in aqueous THF.
【1】
Kim, D.S.H.L. (University of Illinois); Pharmaceutical compsns. useful in the prevention and treatment of beta-amyloid protein-induced disease. WO 0130335 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
22701 |
4-hydroxy-3-methoxybenzaldehyde
|
121-33-5 |
C8H8O3 |
详情 | 详情
|
(II) |
52071 |
3-methoxy-4-(tetrahydro-2H-pyran-2-yloxy)benzaldehyde
|
|
C13H16O4 |
详情 |
详情
|
(III) |
52072 |
1-hydroxyacetone
|
116-09-6 |
C3H6O2 |
详情 | 详情
|
(IV) |
52073 |
1-(tetrahydro-2H-pyran-2-yloxy)acetone
|
|
C8H14O3 |
详情 |
详情
|
(V) |
52074 |
4-hydroxy-4-[3-methoxy-4-(tetrahydro-2H-pyran-2-yloxy)phenyl]-1-(tetrahydro-2H-pyran-2-yloxy)-2-butanone
|
|
C21H30O7 |
详情 |
详情
|
(VI) |
52075 |
(E)-1-hydroxy-4-(4-hydroxy-3-methoxyphenyl)-3-buten-2-one
|
|
C11H12O4 |
详情 |
详情
|
(VII) |
52076 |
(E)-1-hydroxy-4-[3-methoxy-4-[(trimethylsilyl)oxy]phenyl]-3-buten-2-one
|
|
C14H20O4Si |
详情 |
详情
|
(VIII) |
48091 |
(E)-3-(4-hydroxy-3-methoxyphenyl)-2-propenoic acid
|
1135-24-6 |
C10H10O4 |
详情 | 详情
|
(IX) |
52077 |
(E)-3-[3-methoxy-4-[(trimethylsilyl)oxy]phenyl]-2-propenoic acid
|
|
C13H18O4Si |
详情 |
详情
|
(X) |
52078 |
(E)-4-[3-methoxy-4-[(trimethylsilyl)oxy]phenyl]-2-oxo-3-butenyl (E)-3-[3-methoxy-4-[(trimethylsilyl)oxy]phenyl]-2-propenoate
|
|
C27H36O7Si2 |
详情 |
详情
|
合成路线9
该中间体在本合成路线中的序号:
(VII) The condensation of vanillin (VII) with epichlorohydrin (VIII) in ethanolic NaOH produced the glycidyl ether (IX). Epoxide ring opening in (IX) by means of amine (VI) in EtOH furnished amino alcohol (X). The title dihydropyridine derivative was then obtained by reaction between aldehyde (X), methyl acetoacetate (XI), and ammonia under Hantzsch condensation conditions.
【1】
Liang, J.-C.; Chen, I.-J.; Tsai, C.-H.; Liou, S.-F.; Wang, C.-S.; Yeh, J.-L.; The new generation dihydropyridine type calcium blockers, bearing 4-phenyl oxypropanolamine, display alpha-/beta-adrenoceptor antagonist and long-acting antihypertensive activities. Bioorg Med Chem 2002, 10, 3, 719. |
【2】
Lin, T.-H.; Chen, I.-J.; Guaiacoxypropanolamines with alpha/beta-adrenergic blocking activity. EP 1108710; WO 0005209 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(VI) |
31105 |
2-(2-methoxyphenoxy)ethylamine; 2-(2-methoxyphenoxy)-1-ethanamine
|
1836-62-0 |
C9H13NO2 |
详情 | 详情
|
(VII) |
22701 |
4-hydroxy-3-methoxybenzaldehyde
|
121-33-5 |
C8H8O3 |
详情 | 详情
|
(VIII) |
10146 |
Epichlorohydrin; 2-(Chloromethyl)oxirane
|
106-89-8 |
C3H5ClO |
详情 | 详情
|
(IX) |
59599 |
3-methoxy-4-(2-oxiranylmethoxy)benzaldehyde
|
|
C11H12O4 |
详情 |
详情
|
(X) |
59618 |
4-(2-hydroxy-3-{[2-(2-methoxyphenoxy)ethyl]amino}propoxy)-3-methoxybenzaldehyde
|
|
C20H25NO6 |
详情 |
详情
|
(XI) |
11791 |
methyl 3-oxobutanoate; Methyl acetoacetate
|
105-45-3 |
C5H8O3 |
详情 | 详情
|
合成路线10
该中间体在本合成路线中的序号:
(I)
【1】
Cziaky Z 2006.Process for the preparation of entacapone in a stable polymorphic form and preparation of intermediates for its preparation. W0 2006064296 |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
22701 |
4-hydroxy-3-methoxybenzaldehyde
|
121-33-5 |
C8H8O3 |
详情 | 详情
|
(II) |
15283 |
2-cyano-N,N-diethylacetamide
|
26391-06-0 |
C7H12N2O |
详情 | 详情
|
(III) |
66319 |
2-cyano-N,N-diethyl-3-(4-hydroxy-3-methoxyphenyl)acrylamide |
|
C15H18N2O3 |
详情 | 详情
|
(IV) |
66318 |
2-cyano-N,N-diethyl-3-(4-hydroxy-3-methoxy-5-nitrophenyl)acrylamide |
|
C15H17N3O5 |
详情 | 详情
|